Baroda BNP Paribas Value Fund
Direct · GrowthAI Summary
Baroda BNP Paribas Value Fund has consistently outperformed its benchmark, the NIFTY50 Value 20, across all periods, with a 3Y fund CAGR of 8.61% versus 4.23% for the benchmark and positive alpha of 4.20% over 3Y. However, its SIP XIRR of 2.38% over 3Y and 4.37% over 1Y trails the category average SIP XIRR of 16.97% and 11.62% respectively, indicating weak performance relative to value-category peers. Calendar year returns show volatility, ranging from 22.43% in 2023 to -9.6% in 2026.
The fund exhibits defensive characteristics with a beta below 1 (0.92 over 3Y) and downside capture of 85.15% versus upside capture of 91.42% over 3Y, meaning it falls less than the benchmark in declines. Risk-adjusted returns are modest, with Calmar ratios of 0.47 (1Y) and 0.52 (3Y), and one drawdown event exceeding 10% with a recovery still pending after 154 days. The positive alpha across all measured periods from 1Y to 15Y suggests consistent benchmark-relative outperformance despite subdued absolute returns.
The portfolio is diversified across 51 holdings, with the top 10 positions comprising roughly 38% of NAV, led by HDFC Bank (5.41%), ICICI Bank (5.17%), and Reliance Industries (5.16%). Sector allocation is anchored in Banks (17.6%) and Pharmaceuticals (13.3%), with meaningful exposure to Electrical Equipment, Petroleum, and IT. No single stock exceeds 5.5% of NAV, indicating a balanced, non-concentrated approach.
Against category peers, the fund's SIP XIRR significantly lags, with 3Y XIRR of 2.38% versus the category average of 16.97%, placing it in the lower tier of value funds on SIP returns. Lump-sum performance relative to its own benchmark is stronger, with 3Y, 5Y, and 7Y fund CAGRs all exceeding benchmark CAGRs. This divergence suggests the fund has performed better for lump-sum investors than for systematic SIP investors relative to peers.
This fund suits value-oriented investors with a long time horizon of 5-7 years or more who prioritize benchmark-relative outperformance and downside protection over category-leading SIP returns. It is appropriate for investors with moderate risk tolerance who can tolerate periods of weak absolute returns, such as the -9.6% calendar year return in 2026. It may serve as a diversifying allocation within a broader equity portfolio rather than a core growth holding.
- Consistent positive alpha versus the NIFTY50 Value 20 benchmark across all periods, including 4.20% over 3Y and 2.08% over 5Y
- Defensive downside capture of 81-85% across periods, limiting losses relative to the benchmark in declining markets
- Well-diversified portfolio of 51 holdings with no single stock above 5.5% of NAV and a quality tilt toward large-cap banks and pharma
- SIP XIRR of 2.38% over 3Y and 4.37% over 1Y is far below category averages of 16.97% and 11.62%, indicating weak SIP-investor outcomes versus peers
- Ongoing drawdown with no recovery after 154 days and a -9.6% calendar year return in 2026, reflecting prolonged recent underperformance
Generated on 30-10-2026, 2:17 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.10 L | 7.7% | -24.7% | 58.7% |
| 3 Years | ₹36.00 L | ₹37.72 L | 2.5% | -3.5% | 6.2% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY50 VALUE 20 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 7.7% | 14.9% | 11.6% | -7.2% |
| 3 Years | 2.5% | 12.9% | 16.9% | -10.4% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 9.2% | 2.2% | -11.5% | 48.8% | 0.15 | 0.37 | 61% | — | — |
| 3 Years | 10.2% | 10.6% | 7.4% | 12.8% | 2.38 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY50 VALUE 20
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +3.89 | 0.87 | 86.2% | 79.2% | -7.1% | -13.7% |
| 3 Years | +4.58 | 0.92 | 91.2% | 84.1% | 8.6% | 3.8% |
| 5 Years | +2.44 | 0.89 | 88.6% | 82.3% | 6.1% | 3.3% |
| 7 Years | +1.51 | 0.89 | 88.6% | 82.3% | 4.3% | 2.4% |
| 10 Years | +0.83 | 0.89 | 88.6% | 82.3% | 3.0% | 1.6% |
| 12 Years | +0.57 | 0.89 | 88.6% | 82.3% | 2.5% | 1.4% |
| 15 Years | +0.32 | 0.89 | 88.6% | 82.3% | 2.0% | 1.1% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | HDFC Bank Limited | 5.41% |
| 2 | ICICI Bank Limited | 5.17% |
| 3 | Reliance Industries Limited | 5.16% |
| 4 | Bharat Heavy Electricals Limited | 4.52% |
| 5 | Divi's Laboratories Limited | 4.04% |
| 6 | Larsen & Toubro Limited | 3.88% |
| 7 | Sun Pharmaceutical Industries Limited | 2.67% |
| 8 | Torrent Pharmaceuticals Limited | 2.63% |
| 9 | Infosys Limited | 2.43% |
| 10 | Tech Mahindra Limited | 2.39% |